MX2011006254A - Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa. - Google Patents

Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa.

Info

Publication number
MX2011006254A
MX2011006254A MX2011006254A MX2011006254A MX2011006254A MX 2011006254 A MX2011006254 A MX 2011006254A MX 2011006254 A MX2011006254 A MX 2011006254A MX 2011006254 A MX2011006254 A MX 2011006254A MX 2011006254 A MX2011006254 A MX 2011006254A
Authority
MX
Mexico
Prior art keywords
skin lightening
acetylcholinesterase inhibitors
lightening compositions
compositions
inhibitors
Prior art date
Application number
MX2011006254A
Other languages
English (en)
Spanish (es)
Inventor
Stephen Alan Madison
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of MX2011006254A publication Critical patent/MX2011006254A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2011006254A 2008-12-10 2009-12-03 Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa. MX2011006254A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/332,002 US8247405B2 (en) 2008-12-10 2008-12-10 Skin lightening compositions with acetylcholinesterase inhibitors
PCT/EP2009/066349 WO2010066639A2 (en) 2008-12-10 2009-12-03 Skin lightening compositions with acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
MX2011006254A true MX2011006254A (es) 2011-09-01

Family

ID=42231319

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011006254A MX2011006254A (es) 2008-12-10 2009-12-03 Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa.

Country Status (8)

Country Link
US (1) US8247405B2 (OSRAM)
EP (1) EP2355790A2 (OSRAM)
JP (1) JP2012511532A (OSRAM)
CN (1) CN102245165A (OSRAM)
CO (1) CO6361894A2 (OSRAM)
MX (1) MX2011006254A (OSRAM)
WO (1) WO2010066639A2 (OSRAM)
ZA (1) ZA201104223B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
US8440237B2 (en) 2009-04-27 2013-05-14 Mary Kay Inc. Botanical anti-acne formulations
WO2011014649A1 (en) 2009-07-29 2011-02-03 Duke University Compositions and methods for inhibiting hair growth
JP2011105666A (ja) * 2009-11-19 2011-06-02 Kao Corp ドーパオキシダーゼ活性抑制剤及び美白剤
US20120122936A1 (en) * 2010-11-11 2012-05-17 Conopco, Inc., D/B/A Unilever Leave-on nonsolid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid
KR102092977B1 (ko) 2011-12-19 2020-03-24 마리 케이 인코포레이티드 피부톤 향상을 위한 식물 추출물의 조합물
US11446241B2 (en) 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
CA2917815C (en) 2013-07-29 2022-08-30 Attillaps Holdings Organophosphates for treating afflictions of the skin
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
PT3157534T (pt) 2014-06-19 2022-08-04 Attillaps Holdings Inibidores de acetilcolinestérase para o tratamento de condições da dermatológicas
KR102523360B1 (ko) * 2015-12-24 2023-04-18 주식회사 엘지생활건강 쉬잔데린 ａ를 포함하는 피부상태 개선용 조성물
CN111329774A (zh) * 2020-03-30 2020-06-26 香港科技大学 乙酰胆碱脂酶活性抑制剂的新应用
CN121445651A (zh) * 2026-01-05 2026-02-03 广州莱倩化妆品有限公司 一种控油、遮瑕粉底组合物及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA529379A (en) 1952-09-20 1956-08-21 Farbenfabriken Bayer Aktiengesellschaft Phosphonic ester
JPS57102810A (en) * 1980-12-16 1982-06-26 Jiro Isono Cosmetic
IL74497A (en) 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JPH01174389A (ja) * 1987-12-29 1989-07-10 Hayashibara Biochem Lab Inc メラニン生成抑制物質の製造方法とそれを含有する色白剤
US5750542A (en) 1993-09-28 1998-05-12 Pfizer Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
JP3415200B2 (ja) * 1993-06-30 2003-06-09 三省製薬株式会社 皮膚外用剤
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
US5998423A (en) 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
KR100344751B1 (ko) * 1999-12-08 2002-07-20 주식회사 삼양제넥스 멜라닌 합성 저해물질 및 그것을 함유하는 조성물
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6436378B1 (en) * 2001-02-28 2002-08-20 Colgate-Palmolive Company Composition
US6875425B2 (en) 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
JP2004262853A (ja) * 2003-03-03 2004-09-24 Kanebo Ltd 化粧料
JP2004359732A (ja) * 2003-06-02 2004-12-24 Ryukyu Bio Resource Kaihatsu:Kk 抗酸化剤
ES2384878T3 (es) * 2003-11-07 2012-07-13 Basf Beauty Care Solutions S.A.S. Uso cosmético de un extracto de la fruta de Schisandra chinensis
GB0403534D0 (en) * 2003-11-27 2004-03-24 Unilever Plc Stable detergent composition and process to prepare the same
JP4321769B2 (ja) * 2004-04-13 2009-08-26 Ｔｏｗａ Ｃｏｒｐｏｒａｔｉｏｎ 株式会社 抗ヒスタミン用組成物、アレルギ性鼻炎の予防および治療用組成物、花粉症の予防および治療用組成物およびじんま疹治療用組成物
US9186345B2 (en) * 2004-10-12 2015-11-17 Hakon Hakonarson Method of treating skin diseases
ITMI20042413A1 (it) * 2004-12-17 2005-03-17 Indena Spa Processo per la preparazione di galantamina bromidrato
KR100794360B1 (ko) * 2005-07-01 2008-01-15 주식회사 참 존 항염 및 항알레르기 효과를 갖는 문주란 추출물을함유하는 화장료 조성물
US7250158B1 (en) 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
US7247294B1 (en) 2006-03-30 2007-07-24 Conopco, Inc. Skin lightening agents, compositions and methods
US7270805B1 (en) 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
FR2920089A1 (fr) * 2007-08-24 2009-02-27 Greentech Utilisation de 2.2-cyclolignanes comme agents promoteurs de la pigmentation de la peau ou des cheveux
BG110141A (en) * 2008-05-23 2009-12-31 "Софарма" Ад GALANTAMINE DERIVATIVES, METHODS FOR THEIR PREPARATION AND USE

Also Published As

Publication number Publication date
WO2010066639A2 (en) 2010-06-17
CN102245165A (zh) 2011-11-16
US20100143277A1 (en) 2010-06-10
WO2010066639A3 (en) 2011-01-20
CO6361894A2 (es) 2012-01-20
ZA201104223B (en) 2012-09-26
JP2012511532A (ja) 2012-05-24
US8247405B2 (en) 2012-08-21
EP2355790A2 (en) 2011-08-17

Similar Documents

Publication Publication Date Title
WO2010066639A3 (en) Skin lightening compositions with acetylcholinesterase inhibitors
AU2016204344A1 (en) Improved methods and compositions for wound healing
PH12017500930A1 (en) Hsp90 inhibitor combinations
TW201129938A (en) Personal mapping system
CA2713555C (en) Topical compositions and methods for whitening skin
AU313872S (en) Drill shroud
WO2009099719A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
MX2009007254A (es) Composiciones de tableta en tableta.
AU312302S (en) Drill
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
AU2007352537A8 (en) Aluminum hydroxide
WO2009089494A3 (en) Pharmaceutical compositions
MX345909B (es) Anticuerpos anti-fgfr3 y métodos que los utilizan.
WO2008089397A3 (en) Adrb2 cancer markers
IL207372A0 (en) Phenylpyrrole derivatives, compositions comprising the same and uses thereof
ATE533947T1 (de) Einsetzausrüstung und installationsverfahren
MX2009013982A (es) Composiciones que comprenden inhibidores de triptofano hidroxilasa.
MX2009004030A (es) Articulos antimicrobianos y metodos de fabricacion.
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MX2010002667A (es) Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3.
SG143149A1 (en) Phosphite composition and method for producing the same
WO2010068815A3 (en) Compositions and methods for treating cellular proliferative disorders
WO2007146445A3 (en) Individualized pharmaceutical selection and packaging
WO2009101199A3 (en) Treatment of acne vulgaris; rosacea and rhinophym

Legal Events

Date Code Title Description
FA Abandonment or withdrawal